Showing results (101-110 of 250) with videos related to

Sort By:
Pageof 25
Neurology|October 27, 2020
Differential Neuropsychological Profile of Patients With Amyotrophic Lateral Sclerosis With and Without C9orf72 MutationBarbara Iazzolino, Laura Peotta, Jean Pierre Zucchetti, et al.
Journal of Neurology|October 25, 2023
High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosisBarbara Iazzolino, Maurizio Grassano, Cristina Moglia, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 5, 2018
Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controlsLudovic D'hulst, Donatienne Van Weehaeghe, Adriano Chiò, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 23, 2023
Association of MRI leptomeningeal enhancement with disability worsening in progressive multiple sclerosis: A clinical and post-mortem studyMarco Vercellino, Gianfranco Costantini, Maurizio Cogoni, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 24, 2020
Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F-FDG-PET studyAntonio Canosa, Cristina Moglia, Umberto Manera, et al.
European Journal of Neurology|January 8, 2023
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regionsUmberto Manera, Fabrizio D'Ovidio, Sara Cabras, et al.
Neuroimage. Clinical|July 5, 2020
Lifetime sport practice and brain metabolism in Amyotrophic Lateral SclerosisAntonio Canosa, Fabrizio D'Ovidio, Andrea Calvo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 10, 2019
Analysis of the GCG repeat length in NIPA1 gene in C9orf72-mediated ALS in a large Italian ALS cohortLucia Corrado, Maura Brunetti, Alice Di Pierro, et al.
BMJ Open|March 27, 2020
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial)Paolina Salamone, Giuseppe Fuda, Federico Casale, et al.
European Journal of Neurology|November 11, 2020
Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: An 18F-FDG-positron emission tomography studAntonio Canosa, Veria Vacchiano, Fabrizio D'Ovidio, et al.
Pageof 25